GuidelinesBy procedure2026.11.12
Veterinary Medical Device Quality Management — A Table Distinguishing the Scope of the Export GMP Notice from Import Establishment Facilities and Quality Management System (Annex 6-2)
The question ‘there is an export GMP notice, so do imported products need the same audit?’ is answered by separating the scope of application. The notice on manufacturing and quality control standards for export purposes applies to the conformity recognition of manufacturing sites that manufacture solely for export, and does not apply to products for domestic sale. Import establishments must have the facilities and facility standards under Article 13-2 of the Handling Rules and Annex 6-2, Part II. This guide sets out a table distinguishing the two systems, an import establishment facility checklist, an operating records table and the role of the manufacturer's certificates.
Key takeaway — Distinguish three things. (1) Conformity recognition under the Export GMP Notice is a system for manufacturing sites that manufacture solely for export and does not apply to products for domestic sale. (2) An import establishment must have an office, a warehouse, a laboratory (where needed) and the facility standards under Article 13-2 of the Handling Rules and Annex 6-2, Part II, and the test facilities and item-by-item quality control standards under paragraph (3). (3) A manufacturer's certificate such as ISO 13485 is a manufacturer document, not an import establishment requirement.
This article is based on the Rules on the Handling of Veterinary Pharmaceuticals, etc. (MAFRA Ordinance No. 741, in force 31 October 2025) with Annex 6-2, the amended rules promulgated on 30 July 2026 (effective 1 January 2027), and the APQA notices Standards for Manufacturing and Quality Control of Veterinary Medical Devices and Veterinary IVDs for Export Purposes (No. 2024-8, in force 22 February 2024), Regulation on the Approval, etc. of Veterinary Medical Devices (No. 2020-19) and Regulation on the Review of Technical Documents, etc. for Veterinary Medical Devices (No. 2020-18), as checked on 6 October 2026. For the attachments to the import business license, see import business license and product import approval or notification.
System distinction table
| Aspect | Export GMP conformity recognition | Import establishment facilities and quality management system | Manufacturer's quality certificate |
|---|---|---|---|
| Basis | Handling Rules Article 13-2(2) and (4), Annex 6-2 Part I point 3, Notice No. 2024-8 | Handling Rules Article 13-2(2) and (3), Annex 6-2 Part II | Not a statutory requirement. Manufacturer document |
| Subject | A manufacturer manufacturing veterinary medical devices, etc. solely for export that wishes to apply the standards in line with the importing country's requirements | A person seeking veterinary medical device import approval or notification | Overseas manufacturing site |
| Not applicable to | Products for domestic sale (Notice Article 3(i)) | ||
| Content | The 14 items in Annex 6-2 Part I point 3, including the quality management system; the evaluation criteria in Annex 2 of the notice; document review and on-site inspection | Office, warehouse, laboratory (where needed); facilities maintaining condition at import, cold storage or light shielding, and conditions of the prescribed storage method | Certification scope, manufacturing site, validity period |
| Cycle | Periodic audit every 3 years where conformity recognition is to be maintained (Notice Article 5(2)); Annex 6-2 Part I point 3(e)2) also provides for a periodic audit by the APQA Commissioner every 3 years | Inspected periodically and maintained so that import and quality control are not impeded | Certification body cycle |
Article 4(2) of the Approval Notice provides that a person intending to manufacture or import solely for export may omit the documents under Article 5(3)(ii)(b) of the Handling Rules and marks ‘for export only’ in the remarks field of the application, and paragraph (3) requires fresh approval or notification before such an item is marketed domestically. Article 3(2)(vi) of the Review Notice makes a change of approval condition from export-only to domestic sale subject to safety and effectiveness review where it involves a new structure, new performance or the like. Export-only and domestic-sale products part ways not only in the quality system but in the product documents.
Scope of the Export GMP Notice
Article 1 of the notice states that it sets out the details to be observed where, under Article 13-2(2) and (4) of the Handling Rules, manufacturing and quality control standards in line with the importing country's requirements must be applied in manufacturing veterinary medical devices, etc. solely for export. Article 5 divides conformity recognition into initial, additional and change audits and provides that a periodic audit may be undergone every 3 years; Article 6 provides for document review and on-site inspection by product group, with document review only in certain cases. Article 7 requires the application to be accompanied by a copy of the manufacturing business license certificate and an outline of the manufacturing site, etc., and requires a quality control record of at least one manufacturing batch for an approved or notified product.
Do not extend this scope into a claim that there are ‘no’ quality control standards for imported products. Conversely, do not explain that an import establishment must obtain this conformity recognition.
Import establishment facility checklist: Annex 6-2, Part II
| Item | Wording of Annex 6-2, Part II | Check |
|---|---|---|
| Facility (a) | A business office where import operations are conducted | Office location and entry in the statement of facilities and equipment |
| Facility (b) | A warehouse for storing products | Warehouse location, response to product storage conditions |
| Facility (c) | Where testing is needed for quality control, a laboratory and the test facilities needed for that testing. May be dispensed with where testing is outsourced | Whether testing is needed, outsourcing plan |
| Facility standard (a) | Facilities that can maintain the products in their condition at import | Method of maintaining condition after receipt |
| Facility standard (b) | Cold storage facilities or light-shielding facilities (only for products that need cold storage or whose function is impaired by light) | Storage conditions in the manufacturer's instructions |
| Facility standard (c) | Where handling items with a prescribed storage method, facilities that can maintain those conditions | Means of maintaining temperature, humidity, light protection and other conditions |
Part I, point 4 of the same annex and Article 25 of the Approval Notice provide that a manufacturer that outsources manufacturing processes or testing to another manufacturer or a designated test laboratory, etc. may dispense with the related facilities. The proviso to Part II, point 1(c) provides the same for the outsourcing of testing by an import establishment.
Operating records table: link work and records rather than document names
Annex 6-2, Part II sets the facilities; Article 13-2(3) of the Handling Rules requires the importer to have the test facilities needed for manufacturing control and in-house testing, etc. and quality control standards for each manufactured item; and the details are set by APQA Commissioner notice under paragraph (4). The records table below is our own proposal for connecting those requirements to actual work and does not replace the statutory list of obligations.
| Task | Responsible | Check criterion | Record | Action on deviation |
|---|---|---|---|---|
| Receipt | Person in charge | Compare approved product, model, quantity, packaging condition and lot number | Receipt record | Hold release after confirming the discrepancy |
| Storage | Warehouse officer | Maintenance of storage conditions | Temperature and condition record | Evaluate on excursion |
| Release | Person in charge | Model and lot number traceability | Release record | Link to recall response |
| Documents and revisions | Quality officer | Approved content and instructions version | Document register | Withdraw old versions |
| Manufacturer change notification | Quality officer | Changes in parts, raw materials, performance, manufacturing site | Change record | Review impact on approval or notification |
| Complaints and anomalies | Person in charge | Receipt and cause identification | Receipt record | Review actions and reporting |
Suppose fictional importer H introduces a product whose storage conditions are stated in the manufacturer's instructions. Separately from the answer that a warehouse has been secured, H must set out how those conditions are maintained from receipt to release and what is done on an excursion. Test data or the manufacturer's certificate do not substitute for warehouse operation. This example does not require the same temperature range or the same equipment for every product.
Check the scope and linkage of the manufacturer's certificate
The manufacturer's quality system certificate, such as ISO 13485, is used as a manufacturer quality document after confirming the manufacturing site, certification scope, activities covered and validity period. The mere existence of the certificate does not complete the Korean product approval or the import establishment's operational preparation. Set up a communication route so that the effect on the Korean approval or notification content and test data can be checked when the manufacturer changes parts, raw materials, performance or the manufacturing site. Article 7(1) of the Approval Notice makes changes in raw materials, shape and structure, manufacturing method, performance, manufacturer location and the like subject to change approval or notification, so a late change notification from the manufacturer delays the Korean change procedure as well.
Common misunderstandings
| Common explanation | What the provisions provide | What to check |
|---|---|---|
| Imported products also undergo the export GMP audit | Article 3 of the notice does not apply it to products for domestic sale. | Business structure |
| Import establishments have no quality requirements | Article 13-2(2) and (3) and Annex 6-2 Part II set facilities and quality control. | Facility checklist |
| ISO 13485 is enough | It is not written in as a statutory requirement. | Certification scope and import establishment records |
| New import establishment requirements arrive in 2027 | Only the annex number changes to 6-5; the content is the same. | Amendment text |
| A laboratory is mandatory | It may be dispensed with where testing is outsourced. | Outsourcing plan |
The relationship between ISO 13485 and KGMP for human-use medical devices is in ISO 13485 versus KGMP. Veterinary devices follow the Handling Rules and the APQA notice system, not the KGMP conformity assessment procedure, so that article's procedure is not applied as it is.
Documents that speed up the review if prepared before inquiring
- Manufacturing, import and sales structure and whether products are export-only
- Product storage conditions and current plans for the office, warehouse and laboratory (or outsourcing)
- Current list of quality management tasks and record forms
- Scope, manufacturing site and validity period of the manufacturer's quality certificate
Please mention veterinary medical devices in your message when you use the veterinary quality requirements review inquiry. We will review the applicable system, the scope of import establishment preparation, and the linkage of manufacturer documents and operating records. Agency fees, including review of quality documents, are quoted separately according to the scope of work. The scope of services is on the veterinary medical device services page.
Prepared and sources checked: 2026-10-06. Sources: Rules on the Handling of Veterinary Pharmaceuticals, etc. Article 13-2, Annex 6-2 Parts I and II, and Article 13-2(2) of the amended rules promulgated 30 July 2026 (effective 1 January 2027) · Standards for Manufacturing and Quality Control of Veterinary Medical Devices and Veterinary IVDs for Export Purposes (Notice No. 2024-8) Articles 1, 3, 5 to 7 · Regulation on the Approval, etc. of Veterinary Medical Devices Articles 4, 7 and 25 · Regulation on the Review of Technical Documents, etc. for Veterinary Medical Devices Article 3(2). The distinction table, checklist, records table and fictional example are our own practical tools and do not replace the statutory list of obligations. The content of the detailed notice under Article 13-2(4) was not checked for this article.
Frequently asked questions
- Q. Do imported products also need export GMP conformity recognition?
- Article 3 of the Standards for Manufacturing and Quality Control of Veterinary Medical Devices and Veterinary IVDs for Export Purposes defines its scope as cases where conformity recognition is sought in order to apply manufacturing and quality control standards solely for export under Annex 6-2, Part I, point 3 of the Handling Rules, and the periodic audits thereof, and provides that it does not apply to products for domestic sale. The requirements for import establishments are set separately in Annex 6-2, Part II.
- Q. So do import establishments have no quality management standards?
- No. Article 13-2(2) of the Handling Rules sets in Annex 6-2 the facilities and quality management system that a person seeking import approval or notification must have; paragraph (3) requires the importer to have the test facilities needed for manufacturing control and in-house testing, etc. and quality control standards for each manufactured item; and paragraph (4) leaves the details to an APQA Commissioner notice. The fact that the Export GMP Notice does not apply does not mean that no operational preparation is needed.
- Q. If the manufacturer holds an ISO 13485 certificate, are the quality requirements done?
- The Handling Rules and the notices do not list an ISO 13485 certificate as an import establishment requirement or a product approval requirement. The certificate can be used as one of the manufacturer's quality documents after confirming the manufacturing site, certification scope, activities covered and validity period, but it does not substitute for the import establishment's facilities and records system.
- Q. The annex number changes from 2027. Does the content change too?
- In the amended Handling Rules promulgated on 30 July 2026 and effective 1 January 2027, the annex under Article 13-2(2) is renumbered from 6-2 to 6-5. The text of the two annexes differs only in the title line; the content is the same. The substance of the amendment is the GMP system for veterinary pharmaceuticals; no new import establishment requirement for medical devices has been added.
